Literature DB >> 20409228

Hormonal therapy for prostate cancer: current topics and future perspectives.

Hiroyoshi Suzuki, Shiro Hinotsu, Hideyuki Akaza, Yasuhisa Fujii, Satoru Kawakami, Kazunori Kihara, Koichiro Akakura, Motofumi Suzuki, Tadaichi Kitamura, Yukio Homma, Atsushi Mizokami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20409228     DOI： 10.1111/j.1442-2042.2010.02460.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN： 0919-8172            Impact factor:   3.369


× No keyword cloud information.
  2 in total

1.  Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.

Authors:  Daria Pašalić; Paulina Pauković; Selma Cvijetić; Alica Pizent; Jasna Jurasović; Sanja Milković-Kraus; Slavica Dodig; Dorotea Mück-Šeler; Maja Mustapić; Nela Pivac; Mladen Pavlović
Journal:  Genet Test Mol Biomarkers       Date:  2012-03-15

2.  Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction.

Authors:  Defeng Xu; Qiulu Chen; Yalin Liu; Xingqiao Wen
Journal:  Oncotarget       Date:  2017-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.